Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 28% ± 3% | |
glutamatergic neuron | 3 studies | 29% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2134.28 | 2642 / 2642 | 100% | 30.03 | 704 / 705 |
prostate | 99% | 694.29 | 242 / 245 | 100% | 13.32 | 501 / 502 |
thymus | 99% | 662.91 | 647 / 653 | 99% | 11.73 | 597 / 605 |
breast | 98% | 561.44 | 450 / 459 | 99% | 13.74 | 1112 / 1118 |
esophagus | 97% | 571.43 | 1405 / 1445 | 99% | 13.09 | 182 / 183 |
uterus | 99% | 973.85 | 169 / 170 | 97% | 10.11 | 446 / 459 |
bladder | 100% | 656.52 | 21 / 21 | 96% | 8.54 | 484 / 504 |
adrenal gland | 100% | 1086.62 | 258 / 258 | 95% | 21.62 | 218 / 230 |
intestine | 98% | 647.17 | 948 / 966 | 97% | 9.27 | 509 / 527 |
ovary | 98% | 626.51 | 177 / 180 | 96% | 8.13 | 411 / 430 |
stomach | 95% | 457.13 | 340 / 359 | 98% | 10.01 | 279 / 286 |
pancreas | 95% | 429.67 | 312 / 328 | 97% | 7.51 | 172 / 178 |
skin | 96% | 772.84 | 1733 / 1809 | 93% | 13.58 | 441 / 472 |
kidney | 97% | 487.45 | 86 / 89 | 92% | 8.46 | 832 / 901 |
lung | 80% | 385.05 | 461 / 578 | 97% | 8.66 | 1125 / 1155 |
liver | 95% | 432.35 | 214 / 226 | 67% | 3.48 | 273 / 406 |
spleen | 100% | 702.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.99 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 10.00 | 44 / 45 |
adipose | 96% | 470.52 | 1157 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 504.58 | 1267 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 614.75 | 795 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 389.69 | 730 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.40 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 78% | 5.69 | 62 / 80 |
peripheral blood | 60% | 407.86 | 557 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0035020 | Biological process | regulation of Rac protein signal transduction |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | KBTBD6 |
Protein name | Alternative protein KBTBD6 Kelch repeat and BTB domain-containing protein 6 |
Synonyms | |
Description | FUNCTION: As part of the CUL3(KBTBD6/7) E3 ubiquitin ligase complex functions as a substrate adapter for the RAC1 guanine exchange factor (GEF) TIAM1, mediating its 'Lys-48' ubiquitination and proteasomal degradation . By controlling this ubiquitination, regulates RAC1 signal transduction and downstream biological processes including the organization of the cytoskeleton, cell migration and cell proliferation . Ubiquitination of TIAM1 requires the membrane-associated protein GABARAP which may restrict locally the activity of the complex . . |
Accessions | Q86V97 ENST00000379485.2 L8ECN4 |